Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients

OBJECTIVE: Sucroferric oxyhydroxide, a novel iron-based phosphate-binder, has been shown to have beneficial effects in lowering serum phosphorus levels and improving renal anemia in clinical studies. Although an effect of this agent on fibroblast growth factor 23 (FGF23) has been reported in an anim...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Res Notes
Autori principali: Shima, Hisato, Miya, Keiko, Okada, Kazuyoshi, Minakuchi, Jun, Kawashima, Shu
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Note
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994086/
https://ncbi.nlm.nih.gov/pubmed/29884226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-018-3483-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi